Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• DNA double-strand breaks (DSBs) are critical DNA lesions that threaten genome integrity.
• Accurate repair of DSBs is vital for preventing mutations and chromosomal abnormalities.
• Microhomology-mediated end joining (MMEJ) is an alternative DSB repair pathway.
• MMEJ is characterized by the alignment of short homologous sequences (microhomologies) flanking the break.
• This pathway is often associated with insertions and deletions at the repair site, classifying it as error-prone.
• The precise physiological role of MMEJ in normal cells versus its potential involvement in cancer remains an active area of investigation.

Purpose of the Study:

• To review the molecular mechanisms underlying microhomology-mediated end joining (MMEJ).
• To discuss the current understanding of MMEJ's role in maintaining genome stability in normal cells.
• To explore the implications of MMEJ in the context of cancer development and progression.

Main Methods:

• Literature review of recent findings on MMEJ.
• Analysis of studies investigating DSB repair pathways.
• Synthesis of data on MMEJ's mechanistic details and cellular functions.

Main Results:

• MMEJ utilizes microhomologous sequences for end alignment prior to ligation.
• MMEJ is mechanistically distinct from other DSB repair pathways like non-homologous end joining (NHEJ) and homologous recombination (HR).
• MMEJ activity is linked to genomic instability, deletions, insertions, and translocations.
• Evidence suggests MMEJ may play a role in specific physiological contexts, though its exact function is debated.

Conclusions:

• MMEJ is an error-prone DNA double-strand break repair pathway crucial for genome integrity.
• Understanding MMEJ mechanisms and roles is essential for comprehending both normal cellular processes and cancer biology.
• Further research is needed to fully elucidate the physiological significance and therapeutic targeting of MMEJ.